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The exonuclease activity of hPMC2 is required for transcriptional
regulation of the QR gene and repair of estrogen-induced abasic sites
N Krishnamurthy, CR Ngam, AJ Berdis and MM Montano

We have previously reported that the expression of
antioxidative stress enzymes is upregulated by transhydroxytamoxifen (TOT) in breast epithelial cell lines
providing protection against estrogen-induced DNA damage. This regulation involves Estrogen Receptor b (ERb)
recruitment to the Electrophile Response Element (EpRE)
and a novel protein, human homolog of Xenopus gene
which Prevents Mitotic Catastrophe (hPMC2). We have
also demonstrated that ERb and hPMC2 are required for
TOT-dependent recruitment of poly (ADP-ribose) polymerase 1 (PARP-1) and Topoisomerase IIb (Topo IIb) to
the EpRE. Sequence analysis reveals that the C-terminus
of hPMC2 encodes a putative exonuclease domain. Using
in vitro kinetic assays, we found that hPMC2 is a 30 –50
non-processive exonuclease that degrades both singlestranded and double-stranded substrates. Mutation of two
conserved carboxylate residues drastically reduced the
exonuclease activity of hPMC2, indicating the relative
importance of the catalytic residues. Western blot analysis
of breast cancer cell lines for Quinone Reductase (QR)
levels revealed that the intrinsic exonuclease activity of
hPMC2 was required for TOT-induced QR upregulation.
Chromatin immunoprecipitation (ChIP) assays also indicated that hPMC2 was involved in the formation of
strand breaks observed with TOT treatment and is speciﬁc
for the EpRE-containing region of the QR gene. We also
determined that the transcription factor NF-E2-related
factor-2 (Nrf2) is involved in the speciﬁcity of hPMC2 for
the EpRE. In addition, we determined that the catalytic
activity of hPMC2 is required for repair of abasic sites
that result from estrogen-induced DNA damage. Thus,
our study provides a mechanistic basis for transcriptional
regulation by hPMC2 and provides novel insights into its
role in cancer prevention.

Keywords: EpRE; hPMC2; quninone reductase;
tamoxifen

Introduction
Prolonged exposure to estrogen is strongly associated
with an increased risk for developing breast cancer
(Bolton and Thatcher, 2008). However, the precise role
of estrogen in the initiation and progression of breast
cancer has yet to be determined. Cytochrome P450
enzymes catalyze the oxidative metabolism of estrogens
to hydroxy-catecholestrogens that is further oxidized to
its semiquinone and quinone forms (Cavalieri et al.,
2006). The estrogen quinones can form unstable adducts
with DNA, leading to depurination and mutations.
Further, redox cycling between the quinone and
semiquinone produces reactive oxygen species that
accounts for oxidative damage to DNA and lipids
associated with estrogen. The sustained oxidative stress
and the mutagenic potential of these catechol estrogen
quinones may contribute to the initiation while upregulation of mitogenic genes through the Estrogen Receptor
(ER) may facilitate progression of breast cancer (Liehr,
2000; Yager and Davidson, 2006).
The Selective ER Modulator tamoxifen became the
ﬁrst drug to be approved for prophylactic use in the
reduction of risk for breast cancer, showing a 50%
reduction in both non-invasive and invasive breast
cancer (Fisher et al., 1998). Tamoxifen is believed to
protect against breast cancer by blocking the ERmediated transcription of mitogenic genes. However,
we have previously determined that the antioxidative
stress enzyme Quinone Reductase (QR) is upregulated
by tamoxifen in breast epithelial cell lines (Montano and
Katzenellenbogen, 1997; Montano et al., 1998). QR is
known to catalyze the reduction of estradiol-3,4quinone preventing the generation of reactive oxygen
species (Gaikwad et al., 2007). QR expression is also
increased in mammary glands of rats treated with
tamoxifen and this correlates with a decrease in
estrogen-induced DNA damage (Montano et al.,
2007).
Analysis of the QR transcriptional regulation indicates Estrogen Receptor b (ERb) recruitment to the
Electrophile Response Element (EpRE) and involves a
novel protein, human homolog of Xenopus gene which
Prevents Mitotic Catastrophe (hPMC2), also known as
RNA exonuclease 4 homolog (REXO4) (Montano et al.,
1998, 2000). Our previous studies demonstrated a transhydroxytamoxifen (TOT)-dependent, localized co-recruitment of transcription factors ERb, hPMC2, poly
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(ADP-ribose) polymerase 1 (PARP-1) and Topoisomerase IIb (Topo IIb) to the EpRE of the QR gene
(Sripathy et al., 2008). Lack of either ERb or hPMC2
resulted in a complete loss of TOT-induced gene
expression and loss of TOT-dependent decrease in levels
of catechol estrogen quinones. The occupancy of NFE2-related factor-2 (Nrf2) was not dependent on TOT;
however, its recruitment was enhanced by TOT-liganded
ERb and hPMC2. Nrf2 is a transcription factor that is a
regulator of antioxidative response while both PARP-1
and Topo IIb are involved in DNA damage/repair and
allow for transcriptional activation by relaxing chromatin (Nioi et al., 2003; Ju et al., 2006). Our previous
results suggested that ERb and hPMC2 are capable of
assembling an activation complex at the EpRE in
response to TOT. ERb and hPMC2 also regulate
expression and transcription of other antioxidative
enzymes, such as Glutathione S-Transferase Pi (GSTpi)
and gamma-Glutamylcysteine Synthetase Heavy Subunit (GCSh) that are dependent on the EpRE (Montano
et al., 2004).
Our previous work had provided a mechanistic basis
for the protective effects of TOT against estrogeninduced DNA damage and show that it is primarily
mediated by ERb and hPMC2 (Sripathy et al., 2008).
ERb has been suggested to have a protective role against
breast cancer and its elevated levels of expression has
been correlated with a positive response for tamoxifen
treatment (Hopp et al., 2004; Nakopoulou et al., 2004;
Saji et al., 2005). Additionally, our studies imply a
crucial role for hPMC2 in mediating chemoprevention
against breast cancer. However, not much is known
about the biological role of this novel protein. Interestingly, the C-terminus of hPMC2 encodes a putative
exonuclease domain and we speculated that this domain
could have a role in transcriptional upregulation of QR.
Proteins that possess exonuclease domains are involved in a wide variety of cellular functions and have
important roles in repair of DNA breaks, recruitment of
DNA damage/repair factors as well as in transcriptional
regulation (Moser et al., 1997). Work by Ju et al. (2006)
has shown that the enzyme Topo IIb associates itself
with gene promoter regions and is required for sitespeciﬁc double-strand break formation during receptormediated transcriptional activation. The double-strand
break formation creates a signal resulting in activation

of PARP-1 and ultimately serves as a mechanism for
initiation of gene transcription. This work thus mechanistically links the components of DNA damage and
repair machinery to regulated gene transcription.
As a potential target for chemoprevention, it is
important to understand the mechanism of action of
hPMC2, in particular its exonuclease activity, subsequent to its recruitment at the EpRE. We provide
supporting evidence that the exonuclease activity of
hPMC2 is involved in transcriptional regulation of QR
and in repair of estrogen-induced DNA damage.

Results
hPMC2 has a putative exonuclease domain
We have previously shown that hPMC2 is important for
TOT-mediated protection against estrogen-induced
DNA damage (Sripathy et al., 2008). However, not
much is known about the biological role of this protein
apart from its ability to increase transcription from
EpRE-containing promoters of antioxidative stress
enzymes in response to tamoxifen. As the C-terminus
of hPMC2 encodes a putative exonuclease domain, the
enzyme was placed in an exonuclease superfamily that
includes RNases, the proofreading domains of the Pol I
family of DNA polymerases and DNases such as Exo I
(Moser et al., 1997). Homology within the superfamily is
concentrated at three conserved motifs termed ExoI,
ExoII and ExoIII. Nguyen et al. (2001) have characterized one of these exonucleases, Isg20 (interferonstimulated gene product of 20 kDa), that cleaves both
single-stranded RNA and DNA.
To compare Isg20 and hPMC2, we have performed an
amino-acid alignment of the two proteins by COBALT
(Constraint-based Multiple Alignment Tool) (Figure 1).
The sequence alignment reveals that there is a signiﬁcant
homology between the two proteins. Work by Nguyen
et al. (2001) has also shown that Isg20 is a 30 –50
exonuclease, and site-speciﬁc mutations of D11 (in the
ExoI motif), D94 (ExoII) and D154 (ExoIII) resulted in
decreased exonuclease activities. Interestingly, these
amino-acid residues are also conserved in hPMC2. To
characterize the exonuclease activity of hPMC2 and to
understand the role of the conserved amino-acid

Figure 1 Sequence alignment of Isg20 and hPMC2. The amino acid sequence of Isg20 was aligned with the C terminus of hPMC2.
Numbers indicate the amino acid positions and gaps in the alignment are indicated by . The two sequences were aligned using
COBALT from NCBI. The ﬁrst line is the amino acid sequence of Isg20 while the next line indicates the sequence for hPMC2. Two
conserved amino acids in hPMC2 (D247 and D386) enclosed by boxes are the residues that were mutated for the described studies.
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residues in its enzymatic activity, we mutated two of
these residues (D247G/D386G; Figure 1) and cloned it
into a pET28 vector with an N-terminal His tag. The
wild-type (WT) and the double mutant (DM) hPMC2
were puriﬁed as described in ‘Supplementary methods’
(Supplementary Figure 1).
Exonuclease activity of hPMC2
To determine the active site concentration of WT
hPMC2, we performed multiple-turnover experiments,
that is, several rounds of enzyme catalysis, in which the
enzyme concentration is less than the substrate. Under
these conditions, reaction of the single-stranded EpRE
core with WT hPMC2 was characterized by an
exponential burst of product formation, followed by a
slower steady-state phase (Supplementary Figure 2). In
such cases, the amplitude of the burst phase can be used
to determine the amount of active enzyme. The kinetic
experiments revealed that the puriﬁed WT hPMC2 was

either 50% active or existed as a dimer (Hsieh et al.,
1993).
To characterize the exonuclease activity of hPMC2,
we performed single-turnover experiments, that is, one
round of enzyme catalysis, in which enzyme concentration is in excess of the DNA substrate. These experiments were conducted with WT and DM hPMC2 and
with either a single- or a double-stranded substrate
containing the EpRE sequence.
With the single-stranded substrate, an increase in
product formation was observed over the time course of
the reaction (Figure 2a), indicating 30 –50 exonuclease
activity. The appearance of successively shorter 20-mers,
19-mers and so on is consistent with a distributive
enzyme activity as opposed to a highly processive
exonuclease (Skalski et al., 2000). In addition, increasing
the concentration of WT hPMC2 led to increased
product formation along with an increase in the
observed rate constants (Figure 2c; Table 1). With an
increase from 100 to 500 nM WT hPMC2, the observed
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Figure 2 Representative autoradiograms and graphs of single and double stranded substrates with WT and DM hPMC2. Single
turnover experiments, in which enzyme concentration is in excess of DNA, were performed with 20 nM single or double stranded
EpRE substrate and increasing concentrations of either WT or DM hPMC2. The DNA was radioactively labeled on the 50 end and
increasing amounts of the enzyme was added and the reaction monitored for a period of 1 h. Gel images were obtained with a
Molecular Dynamics Storm 840 phosphorimager system and data analysis was performed using ImageQuaNT software. The increase
in product formation observed over the time course of the reaction was then plotted on KaleidaGraph. (a) Representative
autoradiogram of three independent experiments of single stranded EpRE substrate with 500 nM WT or DM hPMC2.
(b) Representative autoradiogram of three independent experiments of double stranded EpRE substrate with 500 nM WT or DM
hPMC2. (c) KaleidaGraph of product formed over time with single stranded EpRE substrate at varying concentrations of WT or DM
hPMC2: 100 nM (), 300 nM (m), 500 nM (’) WT hPMC2 and 500 nM (J) DM hPMC2. The inset shows the same plot over a shorter
time period (12 min) to illustrate the difference in the rate constants at varying concentrations of the enzyme. (d) KaleidaGraph of
product formed over time with double stranded EpRE substrate at varying concentrations of WT or DM hPMC2: 100 nM (), 300 nM
(m), 500 nM (’) WT hPMC2 and 500 nM (J) DM hPMC2.
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Table 1 The observed rate constants (kobs) determined under single
turnover conditions for single and double stranded EpRE substrates
with increasing concentrations of WT hPMC2
kobs (min 1)

WT hPMC2
concentration (nM)
100
300
500

Single stranded

Double stranded

0.62±0.03
1.25±0.06
1.62±0.06

0.093±0.004
0.141±0.008
0.171±0.010

Abbreviations: EpRE, Electrophile Response Element; WT hPMC2,
wild type human homolog of Xenopus gene which Prevents Mitotic
Catastrophe.

rate constant (kobs) increased nearly 2.5-fold from
0.62±0.03 to 1.62±0.06 min 1. With DM hPMC2,
there was o10% product formation over a period of
an hour and increasing concentrations of the enzyme
did not lead to any increase in product formation
(Figures 2a and c).
With the double-stranded EpRE substrate, the trend
observed was similar to the single strand. The WT
enzyme degraded the double-stranded substrate over the
time course of the reaction, with increase in product
formation observed with increased concentration of the
enzyme (Figures 2b and d). With increase in WT
hPMC2 from 100–500 nM, the observed rate constant
(kobs) increased nearly twofold from 0.093±0.004 to
0.171±0.010 min 1 (Table 1). As expected, there was
insigniﬁcant product formation observed with DM
hPMC2. However, with increase in concentration,
hPMC2 degraded the single-stranded substrate more
efﬁciently than the double-stranded EpRE substrate
(Table 1). In fact, at 500 nM WT hPMC2 concentration,
the enzyme degraded single-stranded DNA B10-fold
faster than the double-stranded DNA.
The catalytic activity of hPMC2 is required for
TOT-induced QR expression
We have previously demonstrated a TOT-dependent
recruitment of ERb and hPMC2 to the EpRE, with
subsequent recruitment of other factors to form a coactivator complex, resulting in transcriptional induction
(Sripathy et al., 2008). This recruitment of a co-activator
complex was observed in both the presence (MCF7 cell
line) and absence of ERa (MCF10A-ERb cell line,
MCF10A cells stably transfected with ERb). We also
observed that recruitment of the complex to the QR
promoter resulted in upregulation of QR expression
(Sripathy et al., 2008). However, hPMC2 miRNA
decreased expression of QR and other antioxidative
stress enzymes, indicating that hPMC2 was crucial for
the upregulation of antioxidative enzyme expression.
From our kinetic studies reported above, we showed
that the well-conserved exonuclease domain of hPMC2
is functional. As a result, we determined if the
exonuclease activity had a role in TOT-induced QR
expression.
We used both MCF7 as well as the MCF10A-ERb
cell lines to study TOT-induced QR expression. Both of

these cell lines were transfected with either hPMC2
miRNA that targets hPMC2 30 -UTR or hPMC2
miRNA along with plasmid expressing WT or DM
hPMC2. The cell lines were either untreated or treated
with 10 6 M TOT for 3 h and analyzed via western blot
for expression levels of QR and hPMC2. We conﬁrmed
that hPMC2 protein expression was downregulated in
hPMC2 miRNA cells when compared with control
MCF7 cells. In addition, we also conﬁrmed that
transfection of a plasmid expressing WT or DM hPMC2
in hPMC2 miRNA cells increased hPMC2 protein
expression levels (Figure 3a). As previously reported,
TOT treatment resulted in a signiﬁcant increase in QR
levels in control cells (Figure 3b). However, downregulation of hPMC2 using hPMC2 miRNA resulted in
decreased basal QR expression and no induction of QR
expression was evident after TOT treatment. The
expression of WT hPMC2 was able to rescue TOTinduced QR expression to a signiﬁcant level, while the
exonuclease DM (D247G/D386G) was unable to rescue
TOT-induced QR expression (Figure 3b).
In MCF10A-ERb cells, the trend observed was
similar to that observed in MCF7 cells. There is a
signiﬁcant increase in QR levels after treatment of
control cells with TOT (Supplementary Figure 3).
However, there is a decrease in QR levels after downregulation of hPMC2. In addition, the expression of WT
hPMC2, but not DM hPMC2, was able to rescue TOTinduced QR expression to a signiﬁcant level.
The exonuclease activity of hPMC2 is required for DNA
strand breaks
Previous work by Ju et al. (2006) has shown that Topo
II-mediated DNA strand break is required for regulated
gene transcription. However, this was observed only on
the ERE-containing region of the pS2 promoter in
estrogen-treated MCF7 cells and not with TOT-treated
cells. Previous work in our laboratory indicated a TOTdependent recruitment of ERb and hPMC2 to the
EpRE, with subsequent recruitment of other factors
including Topo IIb to form a co-activator complex,
resulting in transcriptional induction (Sripathy et al.,
2008). Our experiments have proven that the exonuclease activity of hPMC2 is required for TOT-induced
QR expression. As a result, we determined if hPMC2
had a role in the formation of DNA strand breaks
during TOT treatment at the EpRE region of the
QR gene.
DNA strand breaks were detected via 5-bromo-20 deoxyuridine-50 -triphosphate (BrdUTP) labeling by
terminal deoxynucleotidyl transferase (TdT). Chromatin
immunoprecipitation (ChIP) assays were performed
using anti-BrdU antibodies and PCR was performed
to amplify the EpRE-containing region of the QR gene.
We compared DNA strand break formation in MCF7
cells expressing hPMC2 miRNA, hPMC2 miRNA/WT
hPMC2 and hPMC2 miRNA/DM hPMC2. Our results
revealed that there was a threefold increase in DNA
strand breaks after TOT treatment in control MCF7
cells (Figure 3c). However, when hPMC2 was down-
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Figure 3 hPMC2 exonuclease activity is required for TOT induced QR expression and DNA strand breaks. MCF7 cells were
transfected with either hPMC2 miRNA that targets hPMC2 30 UTR or hPMC2 miRNA along with plasmid expressing WT or the DM
hPMC2. Cells were either untreated or treated with 10 6 M TOT for 3 h. (a) Proteins were extracted from cells and processed for
western blot analyses of hPMC2 as described in ‘Materials and methods’. Image shown is representative of three independent
experiments. (b) Proteins were extracted from cells and processed for western blot analyses of QR as described in ‘Materials and
methods’. Levels of QR were quantitated and normalized to GAPDH. The gel image shown is representative of three independent
experiments. Columns in the bar graph represent the fold change in QR levels in control or TOT treated samples. Error bars indicate
s.e.m of three independent experiments. a, signiﬁcance (Po0.05) vs untreated cells; b, signiﬁcance (Po0.05) vs control transfected cells
with the same treatment. (c) DNA strand breaks were detected by BrdUTP labeling by terminal deoxynucleotidyl transferase (TdT)
and ChIP assays were performed using anti BrdU antibodies as described in ‘Materials and methods’. The EpRE containing region of
the QR gene was then ampliﬁed and the bars represent the fold change in DNA strand breaks at the EpRE in control or TOT treated
samples. Error bars indicate s.e.m. of three independent experiments. a, signiﬁcance (Po0.01) vs untreated cells; b, signiﬁcance
(Po0.01) vs control transfected cells with the same treatment.

regulated with miRNA, there was a decrease in
DNA strand breaks to the basal level. Addition of a
plasmid expressing WT hPMC2 partially compensated
for this decrease while addition of the DM did not
result in signiﬁcant increase in strand breaks. This
experiment indicates that the exonuclease activity of
hPMC2 is involved in strand break formation observed
with TOT treatment. In addition to the EpRE region of
the QR gene, we also performed PCR ampliﬁcation of
the ERE-containing region of the ER target gene, pS2.
The results indicated that TOT-induced strand breaks
were speciﬁc for the EpRE region as strand breaks
were not observed in the ERE region (Supplementary
Figure 4).
As hPMC2 is involved in strand break formation, we
determined if it has potential endonuclease activity. As a
result, we performed endonuclease assays based on
previous work by Ando et al. (2008). The assay was
performed with either apurinic/apyrimidinic endonuclease I (APE1) or increasing concentrations of hPMC2
with supercoiled DNA containing the EpRE sequence as
described in ‘Supplementary methods’. Preliminary data
indicates that while APE1 coverts the DNA into the
nicked form, hPMC2 resolves it into nicked and linear
forms suggesting endonuclease activity (Supplementary
Figure 5).

Nrf2 is required for hPMC2 recruitment at the EpRE
region of the QR gene
Transcription factor Nrf2 is essential for the antioxidant
responsive element-mediated induction of phase II
detoxifying and oxidative stress enzyme genes that
respond to agents that cause oxidative stress (Nioi
et al., 2003). We have shown previously that while Nrf2
occupancy at the EpRE was not dependent on TOT, its
recruitment was enhanced by TOT-liganded ERb and
hPMC2 (Sripathy et al., 2008). In order to evaluate if the
recruitment to the EpRE is speciﬁc to TOT, we
performed ChIP assays with raloxifene. Raloxifene, like
TOT, can induce QR and protect against oxidative
damage (Bianco et al., 2003). However, ChIP analysis in
MCF7 cells reveals that raloxifene does not increase the
occupancy of either hPMC2 or Nrf2 at the EpRE
(Supplementary Figure 6A). It is possible that the
structure of the ERb-hPMC2 complex induced by the
ligand is different due to difference in structures between
TOT and raloxifene (Jordan, 1998; Osborne et al.,
2004).
Previous work has shown that downregulation of
hPMC2 with miRNA in presence of TOT abrogated the
enhanced recruitment of Nrf2 (Sripathy et al., 2008). As
this present work focuses on the role of the exonuclease
activity of hPMC2, we were interested if it had a role in

4736

Nrf2 recruitment. MCF7 cells were transfected with
hPMC2 miRNA that targets hPMC2 30 -UTR along
with plasmid expressing WT or DM hPMC2. The cells
were either untreated or treated with 10 6 M TOT for 3 h
and ChIP assays were performed for Nrf2 recruitment at
the EpRE of the QR gene. Addition of WT hPMC2
increased Nrf2 recruitment, while the DM is incapable
of inducing Nrf2 recruitment (Supplementary Figure
6B) at the EpRE. We have shown in this work that WT
hPMC2 can cause DNA strand breaks at the EpRE
while the DM is unable to do so (Figure 3c). It is
possible to speculate that this inability to cause strand
breaks by the DM prevents relaxation of chromatin thus
preventing enhanced Nrf2 recruitment at the EpRE.
Another basis for TOT-induced recruitment of Nrf2 is
upregulation of Nrf2 expression levels. Thus, a time
course experiment was performed in MCF7 cells to
determine the expression levels of Nrf2 in presence of
TOT. Cells were either untreated or treated with 10 6 M
TOT for 45 min, 90 min or 3 h, and Nrf2 levels were
analyzed by western blots. This revealed a signiﬁcant
increase of Nrf2 levels at the 3 h time point (Supplementary Figure 7). We then downregulated Nrf2 with
miRNA in MCF7 cells and the cells were either
untreated or treated with 10 6 M TOT for 3 h and
analyzed via western blot for expression levels of Nrf2.
As expected, the Nrf2 levels increased with TOT
treatment in control MCF7 cells (Figure 4a). When
treated with miRNA, there was a signiﬁcant drop in
Nrf2 expression levels. To ensure the speciﬁcity of the
miRNA against Nrf2, we checked the expression levels
of transcription factors such as hPMC2, ERb, PARP-1,
Topo IIb and RNA Pol II via western blot analysis. The
results (Supplementary Figure 8) reveal that the levels

Nrf2 miRNA
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-

+

+
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are unaffected, indicating the speciﬁcity of the miRNA
against Nrf2.
Our ChIP assay results indicate that the TOT-induced
DNA strand breaks were speciﬁc for the EpRE region of
the QR gene. A possible factor inﬂuencing the recruitment of hPMC2 and thus DNA strand breaks in context
of the EpRE but not the ERE is the presence of Nrf2 in
the EpRE. Thus, we determined the effect of downregulation of Nrf2 on hPMC2 recruitment. The results
revealed a signiﬁcant increase in hPMC2 occupancy at
the EpRE region on TOT treatment when compared
with the control cells (Figure 4b). However, when Nrf2
levels were downregulated with miRNA, hPMC2
recruitment at the EpRE region was attenuated in both
the presence and absence of TOT. This revealed that
Nrf2 is required for hPMC2 recruitment at the EpRE
region of the QR gene.
The catalytic activity of hPMC2 is required for removal
of estrogen-induced abasic sites
An increase in the number of apurinic/apyrimidinic
(AP) sites is a marker for oxidative DNA damage
(Nakamura et al., 2008). The AP sites resulting from
oxidative damage to the deoxyribose moiety of DNA
will lead to aldehydic forms of DNA lesions which, if
not repaired, are promutagenic. Enzymes such as the
human AP endonuclease (APE1) are known to catalyze
the removal of abasic sites and avert potential mutagenic and cytotoxic effects of oxidative damage (Wilson
et al., 1995; Mol et al., 2000).
Our previous work has shown that both ERb and
hPMC2 are required for TOT-mediated protection
against oxidative DNA damage (Sripathy et al., 2008).
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Figure 4 Nrf2 is required for hPMC2 recruitment at the EpRE region of the QR gene. (a) Nrf2 miRNA or control MCF7 cells were
treated with 10 6 M TOT for 3 h. Proteins were extracted from cells and processed for western blot analyses of Nrf2 expression as
described in ‘Materials and methods’. Levels of Nrf2 were quantitated and normalized to GAPDH. The gel image shown is
representative of three independent experiments. Columns in the bar graph represent the fold change in Nrf2 expression levels in
control or TOT treated samples. Error bars indicate s.e.m. of three independent experiments. a, signiﬁcance (Po0.05) vs untreated
cells; b, signiﬁcance (Po0.01) vs control transfected cells with the same treatment. (b) Nrf2 miRNA or control MCF7 cells were treated
with 10 6 M TOT for 3 h and processed and analyzed using ChIP assays and hPMC2 antibody. The EpRE containing region of the QR
gene was then ampliﬁed and the bars represent the mean of three replicate experiments for hPMC2 recruitment. Error bars indicate
s.e.m. of three independent experiments. a, signiﬁcance (Po0.01) vs untreated cells; b, signiﬁcance (Po0.01) vs control transfected cells
with the same treatment.

4737

In addition to its exonuclease activity, we determined if
hPMC2 attenuates estrogen-induced DNA damage by
having a role in its repair. These experiments were
carried out in ERa and ERb negative-MCF10A cells
thus allowing us to control for hPMC2-ERb transcriptional regulation of antioxidative stress enzymes. Cells
were transfected with either hPMC2 miRNA that
targets hPMC2 30 -UTR or hPMC2 miRNA along with
plasmid expressing WT or DM hPMC2. The cells were
untreated or treated with E2 (17-b estradiol) for 24 h and
a biotinylated hydroxylamine aldehyde-reactive probe
was used to detect the abasic sites as explained in
‘Materials and methods’.
Our results revealed that in control MCF10A cells,
treatment with E2 resulted in a threefold increase in the
number of AP sites, indicating that estrogen causes
oxidative DNA damage (Figure 5). When hPMC2 was
downregulated with miRNA, we observed an increase in
number of AP sites not only in E2-treated but also in
untreated cells. To ensure that this was not due to
hPMC2 inhibiting APE1, the major AP endonuclease
involved in repair of abasic sites in the DNA (Wilson
et al., 1995; Mol et al., 2000), we tested the level of
expression of APE1. Western blot analysis reveals that
the level of expression of APE1 is similar in both control
and hPMC2 downregulated cells (Supplementary
Figure 9). We also observed that addition of a plasmid
expressing WT hPMC2 resulted in a decrease in number
of AP sites to the basal level, while addition of the DM
did not. This experiment thus indicates that the
exonuclease activity of hPMC2 is required for repair
of estrogen-induced abasic sites in DNA.
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Figure 5 hPMC2 exonuclease activity is required for repair of
estrogen induced abasic sites. MCF10A cells were transfected with
either hPMC2 miRNA that targets hPMC2 30 UTR or hPMC2
miRNA along with plasmid expressing WT or the DM hPMC2.
Cells were either untreated or treated with 50 nM E2 for 24 h.
Genomic DNA was isolated from cells and processed for aldehyde
reactive probe labeling as described in ‘Materials and methods’.
Columns represent the number of AP sites/105 bp in control or E2
treated samples. Error bars indicate s.d. of two independent
experiments. a, signiﬁcance (Po0.05) vs untreated cells; b,
signiﬁcance (Po0.05) vs control transfected cells with the same
treatment.

Discussion
Our studies provide evidence that hPMC2 has a 30 –50
exonuclease activity and this activity is required for
TOT-dependent QR upregulation and TOT-induced
DNA strand breaks. These DNA strand breaks have
been shown to trigger the recruitment of co-activator
complexes to promoter regions and serve as a general
mechanism for regulated initiation of gene transcription
upon ligand stimulation (Ju et al., 2006). Our studies
also indicate that Nrf2 is required for hPMC2 recruitment at the EpRE region of the QR gene. In addition,
our present work reveals for the ﬁrst time that the
catalytic activity of hPMC2 is required for removal of
estrogen-induced abasic sites in DNA.
Previous work has shown that hPMC2 is important
for TOT-mediated protection against estrogen-induced
DNA damage (Sripathy et al., 2008). Sequence analysis
of hPMC2 indicates that there is a putative exonuclease
domain at amino acids 233–406 that may provide clues
regarding the cellular function of hPMC2 (Moser et al.,
1997). Analysis of WT hPMC2 exonuclease activity
with an EpRE-containing DNA substrate revealed that
hPMC2 degrades DNA in a non-processive manner in
the 30 –50 direction. In addition, WT hPMC2 degrades
single-stranded DNA nearly 10-fold faster than the
double-stranded DNA. Interestingly, other exonucleases
such as TREX1 (DNAse III) and p53 also exhibit nonprocessive excision in the 30 –50 direction preferentially
from single-stranded DNA (Huang, 1998; Hoss et al.,
1999). These enzymes function as proofreading exonucleases for DNA polymerases in DNA repair processes
(Skalski et al., 2000). It is thus possible to speculate that
by virtue of its exonuclease activity, hPMC2 may also
have a role in DNA repair.
To demonstrate the functional relevance of the
exonuclease activity of hPMC2 in antioxidative gene
expression, we downregulated hPMC2 protein expression and showed that decreased hPMC2 levels resulted
in reduced QR levels. The expression of WT hPMC2
was able to rescue TOT-induced QR expression to a
signiﬁcant level unlike the DM (D247G/D386G). Therefore, our studies indicate a critical role for the
exonuclease activity of hPMC2 in QR regulation.
Previous work by Ju et al. (2006) has shown that Topo
II-mediated double-strand break is required for receptormediated gene transcription. We have already shown the
TOT-dependent recruitment of ERb and hPMC2 to the
EpRE, with subsequent recruitment of other factors
including Topo IIb to form a co-activator complex,
resulting in transcriptional induction (Sripathy et al.,
2008). In addition, our ChIP analysis of BrdUTP-labeled
cells indicates that hPMC2 exonuclease activity is required
for DNA strand breaks resulting from TOT treatment.
While hPMC2 is recruited to the ERE after E2 or
TOT treatments; at the EpRE, we observe only TOTdependent recruitment (Sripathy et al., 2008). One
potential basis for the differential activation of EpRE
vs ERE could be the presence of Nrf2 at the EpRE
region. Our ChIP analysis in MCF7 cells with Nrf2
miRNA revealed that downregulation of Nrf2 results in
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decreased recruitment of hPMC2 at the EpRE. This
suggested that Nrf2 has a role in the recruitment of the
ERb–co-activator complex at the EpRE.
Proteins that possess exonuclease domains have
important roles in the repair of DNA breaks, recruitment of DNA damage/repair factors as well as in
transcriptional regulation (Moser et al., 1997). The
well-known APE1 possesses not only DNA repair
activities of AP sites but also has a role in transcription
by redox regulation of Jun binding activity (Xanthoudakis et al., 1992). Similarly, p53 has sequence-speciﬁc
DNA binding activity, which is required for transactivation functions and an exonuclease activity that may be
involved in DNA repair (Marti and Fleck, 2004).
However, the exonuclease activity of these proteins is
separate from its ability to regulate transcription.
In this work, we have presented evidence that the
exonuclease activity of hPMC2 is not only involved in
transcriptional regulation but is also required for repair
of estrogen-induced abasic sites in the DNA. While
hPMC2-mediated regulation of QR and other antioxidative enzymes is crucial for TOT-ERb protection, we
have shown that hPMC2 also has a role in protection
against DNA damage by reducing the number of AP
sites. Our study thus provides evidence for a crucial role
for hPMC2 in transcription as well as in DNA repair. In
turn, this will provide important insights in the role of
estrogen metabolites in breast tumor initiation and
cancer prevention by hPMC2.
Materials and methods
Exonuclease assays
Single turnover experiments, where [Enzyme]>[DNA], were
performed using either the single stranded or the double
stranded EpRE substrate. In each case, the ﬁnal DNA
concentration was 20 nM with increasing concentrations of
either WT or DM hPMC2. All kinetic reactions were
performed at 37 1C, monitored for an hour and quenched at
various time points with 100 mM EDTA. The aliquots were
treated with 5 ml of formamide denaturing dye (90% for
mamide, 0.05% xylene cyanol and 0.05% bromophenol blue in
TBE buffer) and were run on a 20% denaturing polyacryla
mide gel in 1  TBE at 1600 V for 4 h. Gel images were
obtained with a Molecular Dynamics Storm 840 phosphor
imager system (Amersham Biosciences, Piscataway, NJ, USA)
and data analysis was performed using ImageQuaNT software
(version 4.2; Amersham Biosciences). The substrate and
product bands on the gel were quantiﬁed and background in
absence of enzyme was subtracted. The exonuclease products
were plotted on KaleidaGraph version 3.0 (Synergy Software,
Reading, PA, USA) and the observed rate constants were
calculated (Berdis, 2001).

Active site concentration experiments were performed in the
same manner as the single turnover assays using 200 nM single
stranded EpRE DNA and 20 30 nM total protein. Appropriate
ﬁtting of the data using KaleidaGraph allowed for extraction
of the active site concentration (Berdis, 2001).
Western blotting and quantitation
Whole cell lysates were processed and analyzed by western
blotting as previously described (Sripathy et al., 2008).
Chromatin immunoprecipitation
Cells were grown in 100 mm dishes and processed for ChIP
analyses as previously described (Sripathy et al., 2008) with
minor modiﬁcations.
DNA strand break labeling and ChIP
Detection of DNA strand break formation was performed as
previously described with slight modiﬁcations (Ju et al., 2006)
and ChIP was performed with an anti BrdU antibody (BD
Biosciences, San Jose, CA, USA). The EpRE or the ERE
containing regions of the QR or the pS2 gene, respectively,
were ampliﬁed by PCR (Sripathy et al., 2008).
Detection of AP sites
MCF10A cells were treated with either hPMC2 miRNA or
hPMC2 miRNA along with a plasmid expressing WT or DM
hPMC2. The cells were either untreated or treated with 50 nM
E2 for 24 h. DNA extraction was performed with a DNA
isolation kit produced by Dojindo Molecular Technologies
(Rockville, MD, USA). Aldehyde reactive probe labeling and
quantiﬁcation of abasic sites were performed with an AP sites
assay kit (Dojindo Molecular Technologies) as previously
described (Nakamura et al., 2008).
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